{{Rsnum
|rsid=2387100
|Chromosome=13
|position=27852622
|Orientation=plus
|GMAF=0.2727
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Gene=PDX1-AS1
|Gene_s=PDX1-AS1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 46.9 | 46.0 | 7.1
| HCB | 46.7 | 46.0 | 7.3
| JPT | 53.1 | 37.2 | 9.7
| YRI | 58.5 | 34.7 | 6.8
| ASW | 56.1 | 31.6 | 12.3
| CHB | 46.7 | 46.0 | 7.3
| CHD | 45.0 | 42.2 | 12.8
| GIH | 44.6 | 44.6 | 10.9
| LWK | 51.8 | 38.2 | 10.0
| MEX | 44.8 | 46.6 | 8.6
| MKK | 44.2 | 47.4 | 8.3
| TSI | 55.9 | 39.2 | 4.9
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2387100
|Name_s=
|Gene_s=-
|Feature=
|Evidence=PubMed ID:19118814
|Annotation=This variant is significantly associated with late-onset Alzheimer disease (LOAD) in a GWAS study with 492 LOAD cases and 498 cognitive controls using Illumina's HumanHap550 beadchip.
|Drugs=
|Drug Classes=
|Diseases=Alzheimer Disease
|Curation Level=Curated
|PharmGKB Accession ID=PA162363826
}}

{{GET Evidence
|impact=pharmacogenetic
|qualified_impact=Insufficiently evaluated pharmacogenetic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2387100
|overall_frequency_n=27
|overall_frequency_d=128
|overall_frequency=0.210938
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=21
|n_articles=1
|n_articles_annotated=0
|in_pharmgkb=Y
|autoscore=1
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}